QTRX 8-K 2026-11-09

Quanterix Corp (QTRX) 8-K dated 2026-11-09 — accession 0001503274-26-000042.

Quanterix Corp (QTRX) is a medical devices company listed on US.

QTRX to acquire platform ($70M)

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported QTRX revenue for 2025-12-31 was $138.9M. Net income was -$107.2M. Revenue was up 1.1% from 2024-12-31 to 2025-12-31. QTRX currently screens at market cap $274.8M.

Not investment advice. The QTRX SEC hub lists recent forms. The stock page is the research view.